A Randomized Multi-Center, Double-Blind, Placebo-Controlled Study of a New Modified-Release Tablet Formulation of Prednisone (Lodotra) in Patients With Rheumatoid Arthritis.
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2015
At a glance
- Drugs Prednisone (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms CAPRA-2
- Sponsors Horizon Pharma
- 10 Jun 2017 Biomarkers information updated
- 13 Jun 2015 Results of 12 weeks follow up presented at the 16th Annual Congress of the European League Against Rheumatism.
- 14 Nov 2012 Results reporting fatigue scores presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History